20.4 C
New York
Thursday, June 18, 2026

Tag: aging

SOUBEYRAN DEBUTS FRENCH SINGLE MALT WHISKY FROM PROVENCE IN THE U.S. MARKET

Innovative Cask Aging and Distinct Provençal Heritage Set to Capture American Whisky Enthusiasts PARAMUS, N.J., July 29, 2025 /PRNewswire/ -- Crillon Importers is proud to announce...

Invesque Inc. Completes Disposition of 11 Seniors Housing Assets and Manager Changes at Four Other Properties

TORONTO, July 28, 2025 /CNW/ - Invesque Inc. (the "Company" or "Invesque") (TSX: IVQ) (TSX: IVQ.U) announced today that over the last 40 days...

Biologic Therapeutics Market to Hit $794.5 Billion by 2029

"Driven by Rising Chronic Disease Burden and Breakthrough FDA Approvals, Biopharmaceutical Market Surges with Demand for Monoclonal Antibodies, Gene and Cell Therapies, and Innovative...

Biologic Therapeutics Market to Hit $794.5 Billion by 2029

"Driven by Rising Chronic Disease Burden and Breakthrough FDA Approvals, Biopharmaceutical Market Surges with Demand for Monoclonal Antibodies, Gene and Cell Therapies, and Innovative...

Biosurgery Market worth US$21.59 Billion by 2030 with 6.4% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., July 28, 2025 /PRNewswire/ -- The global Biosurgery Market, valued at US$14.96 billion in 2024 stood at US$15.83 billion in 2025 and...

Biosurgery Market worth US$21.59 Billion by 2030 with 6.4% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., July 28, 2025 /PRNewswire/ -- The global Biosurgery Market, valued at US$14.96 billion in 2024 stood at US$15.83 billion in 2025 and...

U.S. Anti-aging Supplements (Collagen, Resveratrol, NMN, Vitamins) Market Trends Analysis Report 2025-2030 | Personalized Nutrition and Advanced R&D Shift Consumer Expectations

The U.S. anti-aging supplements market, valued at USD 1.39 billion in 2024, is projected to grow at a 7.2% CAGR from 2025-2030. Driven by rising health consciousness and proactive aging management, demand for targeted supplements boosts R&D, regulatory support, and e-commerce growth. Key ingredients include collagen and resveratrol.
The U.S. anti-aging supplements market, valued at USD 1.39 billion in 2024, is projected to grow at a 7.2% CAGR from 2025-2030. Driven by rising health consciousness and proactive aging management, demand for targeted supplements boosts R&D, regulatory support, and e-commerce growth. Key ingredients include collagen and resveratrol.

America Must Win the Energy War: CrowdPoint Unveils Strategic Blueprint to Reinvent the U.S. Power Grid

With America’s aging power grid teetering on the brink of collapse, CrowdPoint Technologies President Nadab U. Akhtar has issued a powerful call to arms: it’s time to stop maintaining the grid—and start commanding it.
With America’s aging power grid teetering on the brink of collapse, CrowdPoint Technologies President Nadab U. Akhtar has issued a powerful call to arms: it’s time to stop maintaining the grid—and start commanding it.

Menovelle ‘Coffee Hack’ Fixes Hot Flashes, Belly Weight Gain & Mood Swings, Research Suggests

A Natural Supplement Trend in 2025, Menovelle Helps Women Support Hormonal Balance and Metabolic Energy Without Hormone Therapy or Stimulants
A Natural Supplement Trend in 2025, Menovelle Helps Women Support Hormonal Balance and Metabolic Energy Without Hormone Therapy or Stimulants

Amare Global Launches Skin to Mind™: Skincare Built on Neuroscience + Made with Mental Wellness in Mind

Revolutionary formulas target visible stress signals and support bliss signals at the cutaneous level for results you can see on your skin—and feel within. NEW...

Proteomics Market to Expand Rapidly, with 13% CAGR forecast Through 2030

"Advances in proteomics technologies are driving growth in precision medicine, with rising demand for early diagnostics, personalized therapies, and deeper insights into disease mechanisms." BOSTON,...

Proteomics Market to Expand Rapidly, with 13% CAGR forecast Through 2030

"Advances in proteomics technologies are driving growth in precision medicine, with rising demand for early diagnostics, personalized therapies, and deeper insights into disease mechanisms." BOSTON,...

Donanemab receives positive opinion from the Committee for Medicinal Products for Human Use (CHMP) in early symptomatic Alzheimer’s disease

The opinion will now be referred to the European Commission for final regulatory decision on donanemab  INDIANAPOLIS, July 25, 2025 /PRNewswire/ -- Eli Lilly and...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsAging